PMID- 25971394 OWN - NLM STAT- MEDLINE DCOM- 20151218 LR - 20181202 IS - 1471-2253 (Electronic) IS - 1471-2253 (Linking) VI - 15 DP - 2015 Jan 21 TI - The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex. PG - 7 LID - 10.1186/1471-2253-15-7 [doi] LID - 7 AB - BACKGROUND: Mild hypothermia may be frequently induced due to cool environments in the operating room. The study analyzed patient recovery time and response to sugammadex after a prolonged rocuronium-induced deep neuromuscular block (NMB) during mild hypothermia. METHODS: Sixty patients were randomly (1:1) allocated to the mild hypothermia and normothermia groups, defined as having core temperatures between 34.5-35 degrees C and 36.5-37 degrees C, respectively. Patients received 0.6 mg/kg of rocuronium, followed by 7-10 mug/kg/min to maintain a deep NMB [post-tetanic count (PTC) 1-2]. After surgery, the deep NMB was reversed with sugammadex 4.0 mg/kg. The primary end-point was the time until the train-of-four (TOF) ratio was 0.9. RESULTS: The appropriate neuromuscular function (TOF ratio >/= 0.9) was restored after sugammadex was administered, even after hypothermia. The length of recovery in the hypothermia patients [mean (SD), 171.1 (62.1) seconds (s)] was significantly slower compared with the normothermia patients [124.9 (59.2) s] (p = 0.005). There were no adverse effects from sugammadex. CONCLUSIONS: Sugammadex safely and securely reversed deep rocuronium-induced NMB during mild hypothermia. An additional 46 s was required for recovery from a deep NMB in hypothermia patients. Based on the results, we think this prolonged recovery time is clinically acceptable. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01965067. FAU - Lee, Hee Jong AU - Lee HJ AD - Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, #17 Haengdang dong, Sungdong gu, Seoul, 133-792, Korea. makeitcool@hanmail.net. FAU - Kim, Kyo Sang AU - Kim KS AD - Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, #17 Haengdang dong, Sungdong gu, Seoul, 133-792, Korea. kimks@hanyang.ac.kr. FAU - Jeong, Ji Seon AU - Jeong JS AD - Department of Anesthesiology and Pain Medicine, Samsung Seoul Hospital, Seoul, Korea. wltjs78@hanmail.net. FAU - Kim, Kyu Nam AU - Kim KN AD - Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, #17 Haengdang dong, Sungdong gu, Seoul, 133-792, Korea. vesicle100@naver.com. FAU - Lee, Byeong Chan AU - Lee BC AD - Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, #17 Haengdang dong, Sungdong gu, Seoul, 133-792, Korea. awetkiss@naver.com. LA - eng SI - ClinicalTrials.gov/NCT01965067 PT - Clinical Trial, Phase IV PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20150121 PL - England TA - BMC Anesthesiol JT - BMC anesthesiology JID - 100968535 RN - 0 (Androstanols) RN - 0 (Neuromuscular Nondepolarizing Agents) RN - 0 (gamma-Cyclodextrins) RN - 361LPM2T56 (Sugammadex) RN - WRE554RFEZ (Rocuronium) SB - IM MH - Adult MH - *Androstanols MH - Anesthesia Recovery Period MH - Blood Pressure/drug effects MH - Female MH - Heart Rate/drug effects MH - Humans MH - Hypothermia/*complications MH - Male MH - Middle Aged MH - Neuromuscular Blockade/*methods MH - *Neuromuscular Nondepolarizing Agents MH - Rocuronium MH - Sugammadex MH - Young Adult MH - gamma-Cyclodextrins/*therapeutic use PMC - PMC4430027 EDAT- 2015/05/15 06:00 MHDA- 2015/12/19 06:00 PMCR- 2015/01/21 CRDT- 2015/05/15 06:00 PHST- 2014/09/26 00:00 [received] PHST- 2015/01/15 00:00 [accepted] PHST- 2015/05/15 06:00 [entrez] PHST- 2015/05/15 06:00 [pubmed] PHST- 2015/12/19 06:00 [medline] PHST- 2015/01/21 00:00 [pmc-release] AID - 10.1186/1471-2253-15-7 [pii] AID - 366 [pii] AID - 10.1186/1471-2253-15-7 [doi] PST - epublish SO - BMC Anesthesiol. 2015 Jan 21;15:7. doi: 10.1186/1471-2253-15-7.